Jefferson City Headlines

Liquid biopsy is a rapidly developing alternative for conventional tumor biopsy, with major focus on gathering the most details in molecular cancer to screen for the cancer type requiring the lowest amount of surgical invasion. With rapid developments in NGS technology, liquid biopsies are projected to lead to cancer-related testing and investigation. The Global Liquid Biopsy Market is expected to be valued at USD 3.55 billion by 2027, expanding at a CAGR of 13.6%.

Due to rising cancer prevalence and consequently increasing need for screening and increasing competition between different biotech firms to access untapped markets around the world, the market has been on the rise in most of the regions. Besides, government grants to research institutes are anticipated to develop and enhance the available methods of liquid biopsy testing to help the development of the market.

Get Free Sample PDF Brochure @ https://www.emergenresearch.com/request-sample/34

Liquid Biopsy Market Drivers

The increase in the prevalence of disease combined with minimally invasive cancer detection technologies will also increase market demand. Also, the increasing development and promotion of liquid biopsy assays by leading players is projected to drive the growth of the liquid biopsy market in the forecast period. Growing demand for laboratory services will stimulate segmental growth due to increased cost-effectiveness and a professional workforce shortage. High costs associated with liquid biopsy procedures would also fuel demand for liquid biopsy services in the upcoming years.

Key participants include RainDance Technologies, Personal Genome Diagnostics, Adaptive Biotechnologies, NeoGenomics Laboratories, Guardant Health, Cynvenio, Biocept, Qiagen, Trovagene, and F. Hoffmann-La Roche Ltd., among others.

Attracting the target audience

First, the comprehensive report finds out why customers need a certain product or service. The study focuses on what problems a certain product and service can solve.  Apart from target demographics industry experts weigh up on the factors including audience type, as well as others vital attributes about the target customer segment.

Enquire for customization in Report @ https://www.emergenresearch.com/request-for-customization/34

For the purpose of this report, Emergen Research has segmented the global Liquid Biopsy Market on the basis of Sample Type, Technology, Application, and region:

• Sample Type Outlook (Revenue, USD Billion; 2017-2027)
• Blood Sample-based
• Urine Sample-based
• Other Bio Fluids-based

• Technology Outlook (Revenue, USD Billion; 2017-2027)
• Multi-gene-parallel Analysis (NGS)
• Single Gene Analysis (PCR Microarrays)

• Application Outlook (Revenue, USD Billion; 2017-2027)
• Therapy Selection for Metastatic Breast Cancer
• Therapy Selection for Other Metastatic Cancer
• Molecular Health Monitoring

Get Brief Information https://www.emergenresearch.com/industry-report/liquid-biopsy-market

Regional Outlook

North America dominated the industry with a share of 51.2% in 2019 in terms of revenue due to increased use of liquid biopsy due to increased prevalence of cancer and increased exploration and advancement activities in liquid biopsy combined with sufficient government support. Due to the rising prevalence of diseases, increased awareness of liquid biopsy in people, and enhanced healthcare facilities, Europe is predicted to have the second-largest market share in the projected period.

Table of Content

Chapter 1. Methodology & Sources

    1.1. Market Definition

    1.2. Research Scope

    1.3. Methodology

    1.4. Research Sources

          1.4.1. Primary

          1.4.2. Secondary

          1.4.3. Paid Sources

    1.5. Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2019-2027

Chapter 3. Key Insights

Chapter 4. Liquid Biopsy Market Segmentation & Impact Analysis

    4.1. Liquid Biopsy Market Material Segmentation Analysis

    4.2. Industrial Outlook

          4.2.1. Market indicators analysis

          4.2.2. Market drivers analysis

                    4.2.2.1. Rising application of liquid biopsy due to increasing prevalence of cancers

                    4.2.2.2. Growing interest in liquid biopsy

          4.2.3. Market restraints analysis

                    4.2.3.1. Unclear reimbursement and regulatory scenario associated with liquid biopsy

    4.3. Technological Insights

    4.4. Regulatory Framework

    4.5. Porter’s Five Forces Analysis

    4.6. Competitive Metric Space Analysis

    4.7. Price trend Analysis

    4.8. Covid-19 Impact Analysis

Chapter 5. Liquid Biopsy Market By Sample Type Insights & Trends, Revenue (USD Million), Volume (Kilo Tons)

    5.1. Sample Type Dynamics & Market Share, 2019 & 2027

          5.1.1. Blood Sample based

          5.1.2. Urine Sample based

          5.1.3. Other Bio Fluids based

Chapter 6. Liquid Biopsy Market By Technology Insights & Trends Revenue (USD Million), Volume (Kilo Tons)

    6.1. Technology Dynamics & Market Share, 2019 & 2027

          6.1.1. Multi-gene-parallel Analysis (NGS)

          6.1.2. Single Gene Analysis (PCR Microarrays)

Chapter 7. Liquid Biopsy Market By Application Insights & Trends Revenue (USD Million), Volume (Kilo Tons)

    7.1. Application Dynamics & Market Share, 2019 & 2027

          7.1.1. Therapy Selection for Metastatic Breast Cancer

          7.1.2. Therapy Selection for Other Metastatic Cancer

          7.1.3. Molecular Health Monitoring

Continue…!

Quick Buy https://www.emergenresearch.com/select-license/34

Media Contact
Company Name: Emergen Research
Contact Person: Eric Lee
Email: Send Email
Phone: +1 (604) 757-9756
Address:14671 110 Avenue Surrey, British Columbia, V3R2A9
City: Surrey
State: British Columbia
Country: Canada
Website: https://www.emergenresearch.com/industry-report/liquid-biopsy-market